Impact of duration of untreated illness in bipolar I disorder (manic episodes) on clinical outcome, socioecnomic burden in Egyptian population
- PMID: 33360586
- DOI: 10.1016/j.psychres.2020.113659
Impact of duration of untreated illness in bipolar I disorder (manic episodes) on clinical outcome, socioecnomic burden in Egyptian population
Abstract
Introduction: Bipolar disorder (BD) is a serious and chronic mental illness that may result in disability. We evaluated effect of the duration of untreated of bipolar (DUB) (manic episodes) on clinical outcomes, including episode severity, residual symptoms, duration of hospitalization, and suicide attempts, and on socioeconomic status of patients.
Methods: A total of 216 participants who had bipolar I disorder (manic state) recruited from November 2017-December 2019 from an inpatient psychiatric unit. Patients divided into 2 groups based on DUB: Group A, with DUB < 4 months; and Group B, with DUB ≥4 months. All participants had evaluation for demographic and clinical features, Socioeconomic scale, Young mania rating scale (YMRS) at admission and discharge.
Results: Group A participants were more often male, urban residents, married, literate and educated, professionally employed. Group A had a younger age of onset, less duration of illness, less frequency of episode, less suicide attempts, less duration in hospital, high mean of socioeconomic, lower mean of YMRS at admission and discharge in compared to Group B.
Conclusion: A longer DUB (manic episodes)was associated with negative clinical outcomes (more frequent episode, more symptoms severity, longer hospital admission, more suicide severity, more residual symptoms) and low socioeconomic state of patients with BDI (manic episodes).
Keywords: Bipolar disorder; Duration of untreated; Egypt; Socioeconomic; Young mania rating scale.
Copyright © 2020. Published by Elsevier B.V.
Similar articles
-
[Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].Encephale. 2018 Feb;44(1):14-21. doi: 10.1016/j.encep.2016.08.005. Epub 2016 Oct 11. Encephale. 2018. PMID: 27745717 French.
-
Duration of untreated illness in first-treatment bipolar I disorder in relation to clinical outcome and cannabis use.Psychiatry Res. 2016 Dec 30;246:762-768. doi: 10.1016/j.psychres.2016.07.064. Epub 2016 Oct 28. Psychiatry Res. 2016. PMID: 27814886
-
Concordance of self-rated and observer-rated dysphoric symptoms in mania.J Affect Disord. 2009 Apr;114(1-3):294-8. doi: 10.1016/j.jad.2008.06.015. Epub 2008 Aug 6. J Affect Disord. 2009. PMID: 18684512
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
Cognitive deficits in bipolar disorders: Implications for emotion.Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Clin Psychol Rev. 2018. PMID: 29195773 Free PMC article. Review.
Cited by
-
Factors associated with the frequency of manic and depressive episodes in bipolar disorder: a multicenter study in China.BMC Psychiatry. 2025 May 20;25(1):507. doi: 10.1186/s12888-025-06863-8. BMC Psychiatry. 2025. PMID: 40394517 Free PMC article.
-
Short-Term Effects of Folate Supplementation in Combination With Vitamin B6 for Treating Acute Manic Episodes in Bipolar I Disorder: A Randomized Controlled Trial.Brain Behav. 2025 Apr;15(4):e70432. doi: 10.1002/brb3.70432. Brain Behav. 2025. PMID: 40200764 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical